Northwest & Ethical Investments’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-500
Closed -$95.2K 414
2018
Q3
$95.2K Sell
500
-100
-17% -$18.4K 0.01% 332
2018
Q2
$100K Buy
+600
New +$96.3K 0.01% 349
2017
Q4
Sell
-800
Closed -$164K 371
2017
Q3
$164K Buy
800
+400
+100% +$93K 0.01% 325
2017
Q2
$97.2K Buy
400
+100
+33% +$23.5K 0.01% 345
2017
Q1
$71.7K Hold
300
﹤0.01% 365
2016
Q4
$63K Buy
+300
New +$62.1K ﹤0.01% 370

Other funds holding AGN

Northwest & Ethical Investments's AGN Position: Q4 2018 in Review

Northwest & Ethical Investments sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 500 shares — an estimated $95.2K sold.

Northwest & Ethical Investments first reported a position in AGN in Q4 2016 and held it in 6 quarters. The position peaked at $164K in Q3 2017. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Northwest & Ethical Investments reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Northwest & Ethical Investments sold 500 Allergan plc shares in Q4 2018, an estimated $95.2K.
  • Northwest & Ethical Investments first reported a position in Allergan plc in Q4 2016 and held it in 6 quarters.
  • Northwest & Ethical Investments's Allergan plc position peaked at $164K in Q3 2017.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Northwest & Ethical Investments's 13F filing for Q4 2018, filed 8 Jul 2025.